Research on depression in Parkinson disease: A bibliometric and visual analysis of studies published during 2012–2021

Background:The diagnosis and treatment rate of Parkinson disease (PD) with depression has a low diagnostic rate, and there is no consensus on the choice of treatment mode. This study evaluates the global research trends of scientific outputs related to depression in PD from multiple perspectives, using a bibliometric analysis and visualization tool to scientifically analyze the knowledge from the literature.Methods:Literature related to depression in PD published from 2012 to 2021 was included and selected from the Web of Science Core Collection database in October 2021. CiteSpace software was used to visualize and analyze co-occurrence analyses for countries, institutions, authors, and keywords.Results:A total of 4533 articles from the Web of Science database were included. The United States made the largest contribution with the majority of publications (1215; 29.40%). Toronto University was the most productive institution. PD, depression, quality of life, dementia, nonmotor symptom, prevalence, anxiety, Alzheimer disease, symptom, and disorder would be significantly correlated with depression in PD. The current hot spots in this field focus on the following: risk factors for depression in PD, assessment scale of depression in PD, and rehabilitation of depression in PD.Conclusions:This analysis not only reveals the current research trends and hotspots but also provides some instructive suggestions on the development of depression in PD.     

以针灸为主的综合疗法治疗带状疱疹后遗神经痛临床疗效观察

目的：比较针灸为主的综合疗法与西药治疗带状疱疹后遗神经痛的疗效差异。方法：80例患者随机分为治疗组和对照组,每组各40例。治疗组采用以针灸为主的综合疗法,即电针夹脊穴配合穴位注射,并辅以He-Ne激光治疗。对照组口服羟考酮控释片10 mg,2次/日;甲钴胺片0.5 mg,3次/日。分别记录治疗前后患者疼痛、睡眠障碍、焦虑程度的评分,并统计两组疗效。结果：治疗组的总有效率为100.0%（40/40）,优于对照组的87.5%（35/40）;治疗组的愈显率为85.0%（34/40）,优于对照组的65.0%（26/40,均P〈0.05）。在改善患者的疼痛、睡眠障碍及焦虑程度方面治疗组均优于对照组（均P〈0.01）。结论：针灸为主的综合疗法可有效地治疗带状疱疹后遗神经痛,疗效优于西药组。     

增损柴胡加龙骨牡蛎汤临证思辨录

结合验案,分析柴胡加龙骨牡蛎汤用于治疗痫病、抑郁型精神分裂症（癫病）、绝经期前后诸症、善恐、颈椎病、眩晕、冠心病（胸痹）等杂病的辨治思路。     

基于"欧盟草药专论"解析中药欧盟注册关键问题

欧盟2004/24/EC法令针对传统草药药品实行简化注册程序,很大程度降低了草药药品上市门槛,但法令为其额外设定的注册条件,如草药在欧盟至少药用15年历史要求、适应症限制、给药途径限制等,对非欧洲本土来源的中药产品而言仍面临诸多挑战.鉴于"欧盟草药专论"的评价与草药药品简化注册中安全性和有效性的审评标准基本一致,首次从欧盟草药专论的角度,跟踪欧盟草药专论最新评价进展,对影响欧盟草药专论建立的关键因素以及中药产品简化注册过程中的关键问题进行深入分析,并提出建议与对策,以期为中药产品欧盟注册提供一定指导和参考.     

中医馆健康信息平台建设与发展的思考

在深入分析中医馆健康信息平台建设现状和存在问题的基础上,提出相应对策和建议,以期进一步优化升级中医馆健康信息平台,更好地满足用户需求和业务需求。     

The latest review on the polyphenols and their bioactivities of Chinese Morus plants

The mulberry tree (Morus alba) plays a key role in agriculture, and its different parts have been used as popular Traditional Chinese Medicines for thousands of years. There are 16 species belonging to the Morus genus. Among them, 11 species distribute in China, most of which have been used as the substitutes of M. alba in local provinces. This review summarizes the structural characters of polyphenols, the main components in Morus, including Diels–Alder-type adducts, flavonoids, 2-arylbenzofurans, and stilbenes, and also their related bioactivities in the last 10 years.